Roche Holding AG

ROP.SW · Healthcare · Drug Manufacturers - General · CHF · Fundamentals
Mixed

Physical assets are 30.2% of total assets, a mixed footprint. Capex is 1.11x depreciation and free cash flow yield is still positive, which fits a physical base that is being replaced or expanded without consuming all of its cash. ROIC is 30.4%, above an 8% cost-of-capital hurdle.

Fixed-asset turnover is 2.68x. Compare it with other names in the same basket.

Physical asset ratio
30.2%
Net PP&E plus inventory, divided by total assets. Above 50% is a heavy footprint.
Fixed asset turnover
2.68x
Revenue per dollar of the physical asset base.
Capex / D&A
1.11x
Above 1.0x means the physical base is being replaced or expanded.
Tangible book / share
CHF 13.78
Assets minus goodwill, intangibles, and liabilities, per share.
Price / tangible book
27.51x
Price CHF 379.20.
Fixed-charge coverage
3.40x
EBITDA minus capex, divided by interest plus short-term debt.
FCF yield
4.7%
Latest free cash flow divided by current market cap (CHF 302.13B).
ROIC
30.4%
After-tax operating income over equity plus debt minus cash. Operating income / net PP&E is 0.84x.

Footprint and return

Turnover and reinvestment

Year Physical FAT Capex/D&A TBV/sh Coverage FCF ROIC EBIT/PP&E
2018 36.2% 2.73x 1.12x CHF 14.04 4.34x CHF 15.94B 43.7% 0.87x
2019 35.4% 2.73x 0.81x CHF 17.15 6.80x CHF 18.88B 49.0% 0.90x
2020 35.4% 2.51x 1.47x CHF 10.70 3.42x CHF 11.47B 37.7% 0.76x
2021 34.8% 2.57x 1.02x -CHF 6.27 1.12x CHF 16.02B 35.4% 0.74x
2022 37.2% 2.72x 1.19x CHF 0.86 3.56x CHF 13.34B 32.4% 0.72x
2023 33.9% 2.63x 1.34x CHF 11.25 2.63x CHF 11.45B 27.3% 0.67x
2024 30.8% 2.63x 1.46x CHF 13.69 2.24x CHF 15.09B 20.6% 0.57x
2025 30.2% 2.68x 1.11x CHF 13.78 3.40x CHF 14.08B 30.4% 0.84x
  • Principal due is the current portion of debt.
Latest year inputs (2025)
Net PP&E: CHF 22.93B
Inventory: CHF 7.48B
Total assets: CHF 100.70B
Goodwill: CHF 7.49B
Intangibles: CHF 19.32B
Liabilities: CHF 62.82B
Tangible book: CHF 11.07B
Shares: 803,000,000
Revenue: CHF 61.52B
Capex: CHF 3.75B
D&A: CHF 3.39B
EBITDA: CHF 22.65B
Interest: CHF 1.35B
Short-term debt: CHF 4.21B
Free cash flow: CHF 14.08B
Operating income: CHF 19.26B
Invested capital: CHF 51.52B
Tax rate: 18.7%